GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (MIL:1ORNBV) » Definitions » Capex-to-Operating-Income

Orion Oyj (MIL:1ORNBV) Capex-to-Operating-Income : 0.11 (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Orion Oyj Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Orion Oyj's Capital Expenditure for the three months ended in Sep. 2024 was €-22.40 Mil. Its Operating Income for the three months ended in Sep. 2024 was €202.00 Mil.

Hence, Orion Oyj's Capex-to-Operating-Income for the three months ended in Sep. 2024 was 0.11.


Orion Oyj Capex-to-Operating-Income Historical Data

The historical data trend for Orion Oyj's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Capex-to-Operating-Income Chart

Orion Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.15 0.36 0.17 0.44

Orion Oyj Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.27 0.39 0.24 0.11

Competitive Comparison of Orion Oyj's Capex-to-Operating-Income

For the Drug Manufacturers - General subindustry, Orion Oyj's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Oyj's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Orion Oyj's Capex-to-Operating-Income falls into.



Orion Oyj Capex-to-Operating-Income Calculation

Orion Oyj's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-116.8) / 265.2
=0.44

Orion Oyj's Capex-to-Operating-Income for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-22.4) / 202
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Oyj  (MIL:1ORNBV) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Orion Oyj Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Orion Oyj's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Oyj Business Description

Address
Orionintie 1, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.

Orion Oyj Headlines

No Headlines